상세 보기
Golcadomide (GOLCA) ± Rituximab (RTX) Demonstrates Durable Efficacy and Is Well Tolerated in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (R/R FL): Updated Results from the Phase 1/2 CC-99282-NHL-001 Study
- Chavez, Julio C.;
- Perini, Guilherme Fleury;
- Nastoupil, Loretta;
- Joergensen, Judit Meszaros;
- Bories, Pierre;
- ... Kim, Won Seog;
- 외 13명
Citations
WEB OF SCIENCE
3Citations
SCOPUS
0- 제목
- Golcadomide (GOLCA) ± Rituximab (RTX) Demonstrates Durable Efficacy and Is Well Tolerated in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (R/R FL): Updated Results from the Phase 1/2 CC-99282-NHL-001 Study
- 저자
- Chavez, Julio C.; Perini, Guilherme Fleury; Nastoupil, Loretta; Joergensen, Judit Meszaros; Bories, Pierre; Fontanet, Bijou; Zinzani, Pier Luigi; Munoz, Javier; Giles, Daniel Morillo; Carpio, Cecilia; Costa, Abel; Kim, Won Seog; Rao, Parth; de Moucheron, Berengere; Gang, Yang; Guarinos, Carla; Sudhindra, Akshay; Pourdehnad, Michael; Michot, Jean-Marie
- 발행일
- 2024-11-05
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 144
- 페이지
- 3018 ~ 3020